CRTAC1 and non-small cell lung carcinoma: The results of the apoptosis assay showed that treatment with BAPTA significantly decreased the apoptosis rate of NSCLC cells in the CRTAC1 overexpression group treated with cisplatin (Fig. 7K–N).